Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2010 | 05-2009 | 05-2008 | 05-2007 | 05-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 82 | 173 | 319 | 1,091 | 2,206 |
| Accounts payable and accrued liabilities | 83 | -572 | N/A | N/A | N/A |
| Other Working Capital | 1,569 | -864 | -798 | -290 | -420 |
| Other Operating Activity | -5,260 | -5,354 | -9,772 | -6,686 | -13,652 |
| Operating Cash Flow | $-3,527 | $-6,617 | $-10,251 | $-5,884 | $-11,866 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -161 | -58 | -19 | -68 |
| Purchase Of Investment | N/A | N/A | N/A | -5,017 | N/A |
| Sale Of Investment | 237 | 5,783 | 4,213 | N/A | 11,857 |
| Other Investing Activity | 0 | 0 | -1 | 0 | 0 |
| Investing Cash Flow | $235 | $5,622 | $4,154 | $-5,036 | $11,789 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,337 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,168 | 3,493 | 7,604 | 10,897 | N/A |
| Other Financing Activity | 0 | 0 | -253 | -1,180 | 0 |
| Financing Cash Flow | $-1,170 | $3,493 | $7,351 | $9,716 | $0 |
| Beginning Cash Position | 5,093 | 2,433 | 1,413 | 2,517 | 2,521 |
| End Cash Position | 632 | 4,930 | 2,667 | 1,313 | 2,445 |
| Net Cash Flow | $-4,461 | $2,497 | $1,254 | $-1,204 | $-77 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,527 | -6,617 | -10,251 | -5,884 | -11,866 |
| Capital Expenditure | -2 | -161 | -58 | -19 | -68 |
| Free Cash Flow | -3,529 | -6,779 | -10,309 | -5,903 | -11,934 |